Takeaway
- Women of reproductive age with migraine had greater reductions in attack frequency and duration and greater improvement in migraine-specific quality of life after 8 weeks of soy isoflavones vs placebo.
Why this matters
- Conventional migraine pharmacotherapy has limited efficacy and associated adverse effects and cost.
Key results
- In the...
